Evidence map›Paper›PMID 34208806›Full record

ArticlePathogens (Basel, Switzerland)2021

Esteban Arroyave, Ilirjana Hyseni, Nicole Burkhardt, Yong-Fang Kuo, Tian Wang, Ulrike Munderloh, Rong Fang

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Microbiology spectrum · 2025
    Article
  4. Article
  5. Infection and immunity · 2025
    Article
  6. Article
  7. Article
  8. Critical roles ofInfection and immunity · 2024
    Article
  9. Disarm The Bacteria: What Temperate Phages Can Do.Current issues in molecular biology · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Esteban ArroyaveDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Ilirjana HyseniDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0003-4425-6027
Nicole BurkhardtDepartment of Entomology, University of Minnesota, St. Paul, MN 55108, USA.
Yong-Fang KuoDepartment of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, TX 77555, USA.
Tian WangDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Ulrike MunderlohDepartment of Entomology, University of Minnesota, St. Paul, MN 55108, USA.
Rong FangDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
The University of Texas Medical Branch at Galveston · USUniversity of Minnesota · US

Funding

U.S. Department of Defense W81XWH-18-1-0319
6 · The paper itself

Abstract

Although rickettsiae can cause life-threatening infections in humans worldwide, no licensed vaccine is currently available. To evaluate the suitability of live-attenuated vaccine candidates against rickettsioses, we generated a

Indexed as

attenuated virulencefatal murine rickettsiosesprotective immunityrickettsial mutant

Identifiers

PMID34208806
PMCPMC8308654
OpenAlexW3175148126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.